Latest filing published 13 Jun 2017 for ImmunityBio, Inc..
No signal scores available.
Filings by John T. Potts Jr. span 3 companies, the busiest being Cell Genesys Inc, ImmunityBio, Inc. and ANI Pharmaceuticals Inc. Between 29 June 2007 and 9 June 2017, the trades on record add up to 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 13 June 2017 with a share grant in ImmunityBio, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations